Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium
Authors:
- 14 March 2026
- journal article
- letter
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 67 (6) , 1440-1446
Abstract
Approximately 10% of all cancers worldwide have been attributed to an underlying viral infection [1]. Regarding lymphoid malignancies, viral infections have been linked to several of these cancers ...Keywords
Funding Information
- MGH Lymphoma Research Sundry Funds (K08CA230498)
This publication has 21 references indexed in Scilit:
- Insights into Hepatitis B Virus DNA Integration-55 Years after Virus DiscoveryThe Innovation, 2020
- Characterization of hepatitis B virus infection and viral DNA integration in non‐Hodgkin lymphomaInternational Journal of Cancer, 2020
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceHepatology, 2018
- Global burden of cancers attributable to infections in 2012: a synthetic analysisThe Lancet Global Health, 2016
- Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapyAnnals of Oncology, 2014
- Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicityVaccine, 2012
- Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infectionHepatology, 2007
- Viruses and lymphoma/leukaemiaThe Journal of Pathology, 2005
- Hepatitis B Virus Infection — Natural History and Clinical ConsequencesNew England Journal of Medicine, 2004
- Epidemiology and Prevention of Hepatitis BSeminars in Liver Disease, 2003